Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Glass

Showing results (51-60 of 178) with videos related to

Pageof 18
Sort By:
Brain : a Journal of Neurology|November 17, 2010
SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouseLindsey R Fischer, Anissa Igoudjil, Jordi Magrané, et al.
Nature Reviews. Neurology|December 14, 2011
Translational stem cell therapy for amyotrophic lateral sclerosisNicholas M Boulis, Thais Federici, Jonathan D Glass, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 19, 2015
Applicability of digital analysis and imaging technology in neuropathology assessmentWilliam D Dunn, Marla Gearing, Yuna Park, et al.
The Journal of Clinical Investigation|May 9, 2009
Inactivation of sodium channels underlies reversible neuropathy during critical illness in ratsKevin R Novak, Paul Nardelli, Tim C Cope, et al.
Neuro-Degenerative Diseases|February 28, 2015
Antecedent Disease is Less Prevalent in Amyotrophic Lateral SclerosisCassie S Mitchell, Sabrina K Hollinger, Shivani D Goswami, et al.
Journal of Proteome Research|August 12, 2010
Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approachJian-Ying Zhou, Leila Afjehi-Sadat, Seneshaw Asress, et al.
Human Molecular Genetics|January 30, 2013
Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1CSamuel M Lee, Di Sha, Anum A Mohammed, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemicDanielle Beaulieu, James D Berry, Sabrina Paganoni, et al.
Experimental Neurology|May 15, 2019
Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminalLindsey R Hayes, Seneshaw A Asress, Yingjie Li, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Pageof 18

Showing results (51-60 of 178) with videos related to

Sort By:
Pageof 18
Brain : a Journal of Neurology|November 17, 2010
SOD1 targeted to the mitochondrial intermembrane space prevents motor neuropathy in the Sod1 knockout mouseLindsey R Fischer, Anissa Igoudjil, Jordi Magrané, et al.
Nature Reviews. Neurology|December 14, 2011
Translational stem cell therapy for amyotrophic lateral sclerosisNicholas M Boulis, Thais Federici, Jonathan D Glass, et al.
Neuropathology : Official Journal of the Japanese Society of Neuropathology|November 19, 2015
Applicability of digital analysis and imaging technology in neuropathology assessmentWilliam D Dunn, Marla Gearing, Yuna Park, et al.
The Journal of Clinical Investigation|May 9, 2009
Inactivation of sodium channels underlies reversible neuropathy during critical illness in ratsKevin R Novak, Paul Nardelli, Tim C Cope, et al.
Neuro-Degenerative Diseases|February 28, 2015
Antecedent Disease is Less Prevalent in Amyotrophic Lateral SclerosisCassie S Mitchell, Sabrina K Hollinger, Shivani D Goswami, et al.
Journal of Proteome Research|August 12, 2010
Galectin-3 is a candidate biomarker for amyotrophic lateral sclerosis: discovery by a proteomics approachJian-Ying Zhou, Leila Afjehi-Sadat, Seneshaw Asress, et al.
Human Molecular Genetics|January 30, 2013
Motor and sensory neuropathy due to myelin infolding and paranodal damage in a transgenic mouse model of Charcot-Marie-Tooth disease type 1CSamuel M Lee, Di Sha, Anum A Mohammed, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemicDanielle Beaulieu, James D Berry, Sabrina Paganoni, et al.
Experimental Neurology|May 15, 2019
Distal denervation in the SOD1 knockout mouse correlates with loss of mitochondria at the motor nerve terminalLindsey R Hayes, Seneshaw A Asress, Yingjie Li, et al.
Annals of Clinical and Translational Neurology|November 16, 2016
Predicting disease progression in amyotrophic lateral sclerosisAlbert A Taylor, Christina Fournier, Meraida Polak, et al.
Pageof 18